Carregant...
Cystic fibrosis drug ivacaftor stimulates CFTR channels at picomolar concentrations
The devastating inherited disease cystic fibrosis (CF) is caused by mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) anion channel. The recent approval of the CFTR potentiator drug ivacaftor (Vx-770) for the treatment of CF patients has marked the advent of causative CF th...
Guardat en:
| Publicat a: | eLife |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
eLife Sciences Publications, Ltd
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6594753/ https://ncbi.nlm.nih.gov/pubmed/31205003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.46450 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|